Suchergebnisse - "Paris, Kenneth"

1

Real-World Evidence of Tolerability of 20% Subcutaneous Immunoglobulin Treatment

von: Rosenbach, Kevin

2023, in: Journal of clinical immunology

Wird geladen...
2

Clinical Variability of STAT3 GOF Amongst a Single-Family Cohort

von: Yeager, Jamie

2022, in: Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward

Wird geladen...
3

Ig20Gly Tolerability and Infusion Characteristics in Pediatric and Advanced Age Patients With Primary Immunodeficiency Diseases

von: Paris, Kenneth

2019, in: Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward

Wird geladen...
4

Onboarding Experience of Pediatric Patients With Primary Immunodeficiency Diseases With Subcutaneous Human Immune Globulin 20% (Ig20Gly)

von: Paris, Kenneth

2018, in: Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward

Wird geladen...
5

A clinician’s guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases

von: Epland, Kristin

2022, in: Allergy, asthma and clinical immunology

Wird geladen...
6

Recurrent Human Papillomavirus Infection and Delayed Diagnosis of Idiopathic CD4 Lymphocytopenia

von: Korah-Sedgwick, Michelle

2015, in: Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward

Wird geladen...
7

The Treatment of Primary Immune Deficiencies: Lessons Learned and Future Opportunities

von: Paris, Kenneth

2022, in: Clinical reviews in allergy & immunology

Wird geladen...
8

A New Subcutaneous Immunoglobulin 20% Formulation (SCIG 20%) with Individualized Infusion Parameters Resulted in a Positive Safety and Tolerability Profile in Patients with PIDD in Europe and North America

von: Suez, Daniel

2017, in: Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward

Wird geladen...
9

Response to the Letter to the Editor Regarding “Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials”

von: Suez, Daniel

2017, in: Journal of clinical immunology

Wird geladen...
10

Efficacy, Safety, Tolerability, and Pharmacokinetics of Human Immune Globulin Subcutaneous, 20% (IGSC 20%): Final Analysis of a Phase 2/3 Study in Patients with Primary Immunodeficiency Disease (PIDD) in North America

von: Suez, Daniel

2016, in: Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward

Wird geladen...
11

Analysis of Safety and Tolerability Data in Pediatric Patients with Primary Immunodeficiency Diseases from Two Phase 2/3 Studies of Human Immune Globulin Subcutaneous, 20%

von: Paris, Kenneth

2017, in: Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward

Wird geladen...
12

Health-Related Quality of Life and Health Resource Utilization in Patients with Primary Immunodeficiency Disease Prior to and Following 12 Months of Immunoglobulin G Treatment

von: Routes, John

2016, in: Journal of clinical immunology

Wird geladen...
13

Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America

von: Suez, Daniel

2016, in: Journal of clinical immunology

Wird geladen...
14

Assessment Of The Quality Of Life and Health Resource Utilization Burden Among Patients With Primary Immunodeficiency Disorder (PIDD) Prior To Treatment

von: Routes, John M.

2014, in: Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward

Wird geladen...
15

Progression Of Antibody Defects

von: Myers, Gordon E.

2018, in: The journal of allergy and clinical immunology

Wird geladen...
16

Onboarding Experience of Patients With Primary Immunodeficiency Diseases Who Switched to Subcutaneous Human Immune Globulin 20% (Ig20Gly) From Intravenous or Subcutaneous Immune Globulin 10%

von: Gupta, Sudhir

2018, in: Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward

Wird geladen...
17

Pubertal timing and breast density in young women: a prospective cohort study

von: Houghton, Lauren C.

2019, in: Breast cancer research

Wird geladen...
18

Untargeted serum metabolomic profiles and breast density in young women

von: Jung, Seungyoun

2023, in: Cancer causes & control

Wird geladen...
19

Ataxia Telangiectasia Presenting with Absent IgG, IgA, and Elevated IgM

von: Korah-Sedgwick, Michelle

2016, in: Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward

Wird geladen...
20

Use of Genetic Testing for Primary Immunodeficiency Patients

von: Heimall, Jennifer R.

2018, in: Journal of clinical immunology

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!